---
figid: PMC6417831__nihms-1008924-f0001
figtitle: 'Top panel: The functional effects of a 7-week daily treatment regimen of
  orally administered SU9516 in the mdx mouse model of Duchenne muscular dystrophy'
organisms:
- NA
pmcid: PMC6417831
filename: nihms-1008924-f0001.jpg
figlink: /pmc/articles/PMC6417831/figure/F1/
number: F1
caption: 'Top panel: The functional effects of a 7-week daily treatment regimen of
  orally administered SU9516 in the mdx mouse model of Duchenne muscular dystrophy.
  Bottom panel: Schematic depicting signaling effects of a 7-week daily treatment
  regimen of SU9516 in the inhibition of SPAK/OSR1 and the pro-inflammatory NF-κB
  pathway.'
papertitle: 'Commentary: SU9516 increases α7β1 Integrin and Ameliorates Disease Progression
  in the mdx Mouse Model of Duchenne Muscular Dystrophy.'
reftext: Apurva Sarathy, et al. J Rare Dis Res Treat. 2017;2(5):1-4.
year: '2017'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8148822
figid_alias: PMC6417831__F1
figtype: Figure
organisms_ner:
- Drosophila melanogaster
redirect_from: /figures/PMC6417831__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6417831__nihms-1008924-f0001.html
  '@type': Dataset
  description: 'Top panel: The functional effects of a 7-week daily treatment regimen
    of orally administered SU9516 in the mdx mouse model of Duchenne muscular dystrophy.
    Bottom panel: Schematic depicting signaling effects of a 7-week daily treatment
    regimen of SU9516 in the inhibition of SPAK/OSR1 and the pro-inflammatory NF-κB
    pathway.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Grip
  - Grip128
  - Orai
  - Kg
  - egh
  - LanB1
  - betaTub56D
  - mys
  - Prosbeta1
  - Prosalpha7
  - dl
  - wash
  - Dif
  - Rel
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
---
